Top Markets
#1 EXOD EXOD +56.80%
#2 Glidr Glidr +34.56%
#3 CoW Protocol CoW Protocol +25.51%
#4 Cysic Cysic +22.50%
#5 Nockchain Nockchain +18.81%
#6 Nillion Nillion +14.26%
#7 FOLKS FOLKS +13.09%
#8 Versatize Coin Versatize Coin +12.49%
#9 Fabric Protocol Fabric Protocol +12.46%
#10 Tutorial Tutorial +11.73%
Coin of the day
EXOD EXOD
Settings
Language
ENGLISH
Currency
USD
Theme
Kelyniam Global, Inc. Kelyniam Global, Inc.

Kelyniam Global, Inc.

KLYG
Rank in Stocks #37387
Kelyniam Global, Inc. operates as a medical device manufacturer, providing... Kelyniam Global, Inc. operates as a medical device manufacturer, providing specialized solutions for patients. The company creates custom prosthetics using computer-aided design (CAD) and manufacturing (CAM) processes, employing advanced medical-grade polymers. Additionally, Kelyniam develops, produces, and supplies specific cranial and craniofacial fixation screws, crucial for the reconstruction of skull and facial structures. Its clientele encompasses health systems, hospitals, sales representatives, surgeons, insurance providers (payors), and individual patients. Established in 2005, the company was originally named Ketner Global Investments, Inc., rebranding to Kelyniam Global, Inc. in December 2007. Kelyniam Global is based in Collinsville, Connecticut.
Share Price
$0.14
Last synced: 2026-08-13
Market Cap
$1.76M
Change (1 day)
0.00%
Change (1 year)
133.33%
Country
US
Trade Kelyniam Global, Inc. (KLYG)

Category

Healthcare
Revenue for Kelyniam Global, Inc. (KLYG)
Revenue in Aug 2026 TTM: 0
According to Kelyniam Global, Inc. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Kelyniam Global, Inc. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 $46.59B -
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 $25.84B -
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
 $35.48B -
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 $21.00B -
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
 $6.51B -
US